Skip to Main Content


Skip Nav Destination



Rory Williams
Director of Communications and Marketing

Ben Short
Senior Science Writer

Follow us on Twitter: JCB | JEM | JGP | RUP

Embargoed media alerts and PIO Tip Sheets

Sign up for a weekly preview of articles to be published in JCB, JEM, and JGP by contacting Rory Williams. Media alerts are for journalists only. RUP also posts PIO Tip Sheets in EurekAlert every Tuesday to notify authors’ institutions of articles that have been accepted for publication in RUP journals. You may also visit the RUP page on Newswise.

Latest Press Releases

View all press releases...

Recent media coverage

9/29/20 – Acid reflux drug could help newborn babies recover from brain injury, study suggests – Journal of Experimental Medicine
The Medical News, MedicalXpressSciencenewsnet, MedIndia, Infosalus, Infobae, Medical Dialogues
RUP Press Release - Article

9/14/20 – DNA webs may drive lung pathology in severe COVID-19 – Journal of Experimental Medicine
GEN NewsTechnology NetworksInfosurhoy, Laboratory Equipment, SciTech Daily, MSN, The Print, The Medical News, Bionewscentral, MedicalXpress, ScienMag, Science Daily, ScienceNewsNet, BeScienced, Bioengineer, DH, Trust My Science, Clinical OMICs, Science Codex, FirstPost, Bio-IT World
RUP Press Release - Article - Article

9/4/2020 – Unconventional T cells in severe COVID-19 patients could predict disease outcome – Journal of Experimental Medicine
La Nouvelle RepubliqueMicrobe PostThe Medical News, ScienceNewsNetMedIndia, Science Daily, MedicalXpressBionewscentral, ScienMag, Bioengineer, Bio-IT World, Science Codex, LabMedica
RUP Press Release - Article

8/27/2020 – Researchers identify mechanism underlying cancer cells' immune evasion – Journal of Experimental Medicine
Fierce Biotech, eCancer, Science Daily, Medical XpressThe Medical NewsScienceNewsNet, ScienMag,, The,, kknews, MedSci News
RUP Press Release - Article

8/27/2020 – Researchers identify RNA molecule that helps lung cancer cells evade immune system – Journal of Cell Biology
Fierce Biotech, Agencia SINC, ScienMag, MSN, EbiotradeScienceNewsNet, Infosalus, Heraldo Spain, Diario Sigla XXI, Science Daily, Yahoo Noticias, The Medical News, Medical Xpress, Newsweek Mexico,
RUP Press Release - Article

8/4/2020 – Researchers develop new mouse model for SARS-CoV-2 – Journal of Experimental Medicine
Technology Networks, Infosurhoy, MedicalXpressThe Medical News, ScienMag, Bioengineer, ScienceNewsNet, TekCrispy, Science Daily, Bio-IT World
RUP Press Release - Article

7/24/2020 – Researchers make significant step toward blood test for Alzheimer's disease – Journal of Experimental Medicine
New York Times, CNN, The TimesSt. Louis Post-DispatchIFLScience, Irish Times, Evening StandardNew AtlasFuturity, CosmosMedscape, Technology Networks, Yahoo News, MedPageToday, WebMD, AlzForum, Daily Mail, and more.
RUP Press Release - Article

7/21/2020 – Researchers develop new tools to rapidly test activity of anti-coronavirus antibodies – Journal of Experimental Medicine
The Science Advisory BoardThe Medical News, MedicalXpress, ScienMagScienceNewsNet, Infosurhoy, Social News, MedIndia, CanIndia, SIFY News, Pro Kerala, Telengana Today, Daily Hunt, Daiji World, New Kerala, India4U, Sakal Times, NetIndia123, Infosalus, Redaccion Medica, Bioengineer, Ommcom News, EdEx Live
RUP Press Release - Article

7/9/2020 – Breast cancer cells turn killer immune cells into allies – Journal of Cell Biology
Fierce Biotech, GEN NewsTechnology NetworksYahoo, The Medical NewsMedicalXpress, Clinical OMICsDrug Target Review, ScinexxeCancer, Bionity, LabOnlineScienMagSciencenewsnet, Infosurhoy, Infosalus, Infobae, Bioengineer
RUP Press Release - Article

6/19/2020 – Early clinical trial supports tumor cell-based vaccine for mantle cell lymphoma – Journal of Experimental Medicine
MedicalXpress, The Medical NewsScienMag, eCancer, InfosalusSciencenewsnet, InfosurhoySputnik News, Bioengineer
RUP Press Release - Article

6/4/2020 – Continued nicotine use promotes brain tumors in lung cancer patients, study suggests – Journal of Experimental Medicine
IFLScience, Fast CompanyDaily Mail, Best Life, RT MagazineeCancer, Oncology News, Cancer Nursing TodayThe Medical NewsMedicalXpress, Sciencenewsnet, BioengineerEl Nacional, International Business TimesThe Amed Post, Express Informer, La ConexionUSA, Infosalus, Social News, CanIndia, ProKerala, Outlook India, Daijiworld, New Kerala, Tribune India,, India4U, NetIndia123, What's New, Medical Dialogues, SciTech Daily, New Telegraph, Science Daily, Newsgram, Odisha, Daily Hunt, TimesNowNews, Zona Cero, Nvi Noticias, ABC Color, La Voz Digital,, El Nuevo Herald, La Tribuna, Diario Libre, Infobae, Alianza Metropolitan News, Opinión, La Prensa, National Herald, Meaww, Explica, Sputnik News, Medical Brief, Medical Daily, MSN, NYCT
RUP Press Release - Article

Embargo policy

Rockefeller University Press (RUP) makes embargoed material available to eligible journalists and public information officers for research articles appearing in its three journals: Journal of Cell Biology, Journal of Experimental Medicine, and Journal of General Physiology. Eligible individuals must agree to follow the terms of the RUP embargo policy:

  • Stories or reports on research articles may not be published or placed in the public domain until 10:00 a.m. US Eastern Time on the day of publication. Precise embargo dates and times are clearly marked on all advance material.
  • Public information officers (PIOs) may not distribute embargoed materials in the public domain before the embargo date. However, embargoed materials may be distributed to the media by public information officers. Such releases must be clearly identified as embargoed and must include the embargo date and time. PIOs are responsible for taking all necessary steps to ensure that the embargo is honored by all third parties.
  • All material from RUP journals can be reused without permission for noncommercial purposes, but must be attributed to the appropriate journal and shared expressly under the same restrictions. See our Creative Commons policy for more information.
Close Modal

or Create an Account

Close Modal
Close Modal